BrainStorm-Cell Therapeutics Inc., a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced, that the Company will hold a conference call to update shareholders on financial results for the first quarter ended March 31, 2020, and provide a corporate update, at 8:30 a.m, Eastern Daylight Time, on Thursday, May 7, 2020.
April 29, 2020
· 5 min read